AVNS   $24.785  0.26% Market Open

Avanos Medical, Inc.
Total Cash 89.00M
totalCashPerShare 1.935
EBITDA 102.20M
Total Debt 202.20M
quickRatio 1.038
currentRatio 2.22
Total Revenue 681.50M
debtToEquity 16.443
Revenue/Share 14.791
ROA 0.02081
ROE 0.0177
grossProfits
freeCashflow 140.15M
operatingCashflow 55.50M
earningsGrowth
revenueGrowth -0.005
grossMargins 0.55509996
ebitdaMargins 0.14996
operatingMargins 0.096829996
profitMargins 0.023039998
enterpriseValue 1.02B
forwardPE 11.844312
floatShares 41.89M
sharesOutstanding 45.96M
sharesShort 754.81K
sharesShortPriorMonth 819.46K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.94%
Short Ratio help_outline 3.19%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 26.733
Price To Book help_outline 0.74
earningsQuarterlyGrowth
netIncomeToCommon 21.70M
trailingEps 0.47%
forwardEps 1.67%
enterpriseToEbitda 10.01
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.4 4Q 2024
institutionsCount 359
lastUpdated Nov. 6, 2024, 3:31 p.m.